CN106511676A - 一种临床护理上用于治疗褥疮的中药组合物 - Google Patents
一种临床护理上用于治疗褥疮的中药组合物 Download PDFInfo
- Publication number
- CN106511676A CN106511676A CN201611002705.2A CN201611002705A CN106511676A CN 106511676 A CN106511676 A CN 106511676A CN 201611002705 A CN201611002705 A CN 201611002705A CN 106511676 A CN106511676 A CN 106511676A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- herba
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 230000000474 nursing effect Effects 0.000 title claims abstract 4
- 208000004210 Pressure Ulcer Diseases 0.000 title abstract 4
- 241000628997 Flos Species 0.000 claims abstract description 23
- 241000237903 Hirudo Species 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 23
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 23
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 9
- 241000237502 Ostreidae Species 0.000 claims abstract 3
- 235000020636 oyster Nutrition 0.000 claims abstract 3
- 208000025865 Ulcer Diseases 0.000 claims description 45
- 231100000397 ulcer Toxicity 0.000 claims description 43
- 244000293323 Cosmos caudatus Species 0.000 claims description 22
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 22
- 241000239226 Scorpiones Species 0.000 claims description 22
- 239000009286 sanguis draxonis Substances 0.000 claims description 22
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 21
- 241001550206 Colla Species 0.000 claims description 16
- 241000209020 Cornus Species 0.000 claims description 16
- 238000010025 steaming Methods 0.000 claims description 13
- 239000003390 Chinese drug Substances 0.000 claims description 12
- 235000011837 pasties Nutrition 0.000 claims description 12
- 238000013329 compounding Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 6
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 5
- -1 lanoline Substances 0.000 claims description 5
- 239000003883 ointment base Substances 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 239000005844 Thymol Substances 0.000 claims description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 229960000790 thymol Drugs 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 claims description 2
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 claims description 2
- WYJIGXADTWKYJD-UHFFFAOYSA-N C(C(C)O)O.C1(=CC=CC=C1)C1=CC=C(C=C1)Cl Chemical compound C(C(C)O)O.C1(=CC=CC=C1)C1=CC=C(C=C1)Cl WYJIGXADTWKYJD-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- 229940092782 bentonite Drugs 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 2
- 239000007766 cera flava Substances 0.000 claims description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 2
- 229960004926 chlorobutanol Drugs 0.000 claims description 2
- 229940031956 chlorothymol Drugs 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- 229930003633 citronellal Natural products 0.000 claims description 2
- 235000000983 citronellal Nutrition 0.000 claims description 2
- 238000005260 corrosion Methods 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- SCWKRWCUMCMVPW-UHFFFAOYSA-N phenyl n-methylcarbamate Chemical compound CNC(=O)OC1=CC=CC=C1 SCWKRWCUMCMVPW-UHFFFAOYSA-N 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229940084106 spermaceti Drugs 0.000 claims description 2
- 239000012177 spermaceti Substances 0.000 claims description 2
- 229960004274 stearic acid Drugs 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims 1
- 241000251468 Actinopterygii Species 0.000 claims 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 240000004307 Citrus medica Species 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 230000031709 bromination Effects 0.000 claims 1
- 238000005893 bromination reaction Methods 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 229960005323 phenoxyethanol Drugs 0.000 claims 1
- 235000020995 raw meat Nutrition 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 238000005469 granulation Methods 0.000 abstract description 7
- 230000003179 granulation Effects 0.000 abstract description 7
- 210000001519 tissue Anatomy 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000001338 necrotic effect Effects 0.000 abstract description 3
- 230000000740 bleeding effect Effects 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 210000000981 epithelium Anatomy 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000132171 Phryma leptostachya Species 0.000 abstract 1
- 235000002634 Solanum Nutrition 0.000 abstract 1
- 241000207763 Solanum Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000001816 cooling Methods 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- FBZAJTXIEOKQDV-UHFFFAOYSA-N CC1=C(C=CC=C1)O.[Cl] Chemical compound CC1=C(C=CC=C1)O.[Cl] FBZAJTXIEOKQDV-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- YAVVGPBYBUYPSR-UHFFFAOYSA-N benzene;oxygen Chemical compound [O].C1=CC=CC=C1 YAVVGPBYBUYPSR-UHFFFAOYSA-N 0.000 description 1
- RRTCFFFUTAGOSG-UHFFFAOYSA-N benzene;phenol Chemical compound C1=CC=CC=C1.OC1=CC=CC=C1 RRTCFFFUTAGOSG-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Insects & Arthropods (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种临床护理上用于治疗褥疮的中药组合物,涉及中药技术领域,所述临床护理上用于治疗褥疮的中药组合物,由薄荷、珍珠粉、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭、鹿角胶制成,本发明提供的治疗褥疮的中药,具有活血化於,生肌、祛风止痛的效果,还具有止血、化脓、消炎、去腐生肌的效果,治疗患处时能及时清除坏死组织,创面清洁有利于肉芽及上皮的再生,和现有技术相比,具有药效显著、治疗周期短、用药安全、可靠,方法简便、易行的特点。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种临床护理上用于治疗褥疮的中药组合物。
背景技术
长期卧床患者,由于体力极度虚弱或运动功能丧失,无力变换卧位,加之护理不当,易导致位于体表骨隆突和床褥之间的皮肤组织或肌肉因持续受压、局部缺氧、血管栓塞、组织坏死腐脱而形成溃疡,称为褥疮。
褥疮具有发病率高、病程发展快、难以治愈和治愈后易复发的特点。有的病人刚开始发生的褥疮只有1元硬币大小,由于处理不当,仅几个月就发展成碗口大的重症褥疮。褥疮给上述患者带来极为痛苦的折磨,腐肉片生始筋着骨,甚至在一些卫生条件不好的地方,容易导致脓毒症、骨髓炎和低蛋白血症等一系列并发症,还会导致生虫,令人望而生畏,死于褥疮病的患者很多,如褥疮引起的败血症,破伤风及心肺感染等。同时,褥疮在治疗上也较为困难,它所导致的并发症不仅使原有的疾病治疗更加困难,甚至某些时候会直接加速病人的死亡。
目前,西药虽有一些治疗褥疮的药品,但其临床应用的效果不好,且价钱昂贵,治疗不理想,二市场上治疗褥疮的中药的疗效欠佳,中国专利CN1463740A公开了一种由蛋黄油、核桃油、芝麻油制成的治疗褥疮的中药制剂,该制剂对疮面有保护作用,有利于肉芽组织的生长,对轻度褥疮有一定疗效,但对褥疮已经溃烂,腐肉及脓水较多的蕴毒腐溃证病例疗效欠佳,因此,褥疮也被很多医生及患者家人说是无药可治。
发明内容
针对现有技术的不足,本发明提供了一种临床护理上用于治疗褥疮的中药组合物,它具有种疗效好、见效快、使用方便、治疗成本低的特点。
为实现以上目的,本发明通过以下技术方案予以实现:
一种临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷20~35份、珍珠粉15~20份、黄芪5~35份、红花10~25份、川芎5~20份、白毛藤5~20份、何首乌8~20份、紫草10~18份、三七3~18份、透骨草5~15份、狗脊6~15份、蝎尾6~12份、黄柏3~10份、鱼腥草3~10份、煅牡蛎3~8份、血竭3~8份、水蛭3~5份、鹿角胶3~5份。
优选的,所述临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷25份、珍珠粉15份、黄芪30份、红花25份、川芎15份、白毛藤10份、何首乌15份、紫草10份、三七10份、透骨草5份、狗脊12份、蝎尾10份、黄柏5份、鱼腥草10份、煅牡蛎5份、血竭8份、水蛭3份、鹿角胶5份。
优选的,所述临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷30份、珍珠粉20份、黄芪28份、红花18份、川芎15份、白毛藤20份、何首乌20份、紫草18份、三七18份、透骨草15份、狗脊6份、蝎尾10份、黄柏10份、鱼腥草8份、煅牡蛎3份、血竭5份、水蛭3份、鹿角胶5份。
优选的,所述临床护理上用于治疗褥疮的中药组合物与软膏基质、抗氧剂或防腐剂复配可制成中药软膏。
优选的,所述软膏基质为凡士林、石蜡、羊毛脂、蜂蜡、鲸蜡、二甲基硅油、硬脂酸、十八醇、植物油、PEG、FAPG、海藻酸钠、皂土、卡波姆、果胶中的一种或多种组合物。
优选的,所述抗氧剂为VE、没食子酸烷酯、丁羟基茴香醚、丁羟 基甲苯、抗坏血酸、异抗坏血酸、亚硫酸盐、枸橼酸、酒石酸、巯基二丙酸中的一种或多种组合物。
优选的,所述防腐剂为异丙醇、氯丁醇、三氯叔丁醇、苯基-对-氯苯丙二醇、苯氧乙醇、溴硝基丙二醇、苯甲酸、丙酸、山梨酸、肉桂酸、茴香醚、香茅醛、丁子香酚、香兰酸酯、苯酚、苯甲酚、麝香草酚、对氯邻甲苯酚、对氯间二甲苯酚、煤酚、氯代百里酚、水杨酸、对羟基苯甲酸酯、苯扎氯铵、溴化烷基三甲基铵、葡萄糖酸洗必泰中的一种或多种。
优选的,所述临床护理上用于治疗褥疮的中药组合物的制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入软膏基质、抗氧剂或防腐剂复配制成中药软膏。
本发明的有益效果:薄荷,味辛能散,性凉而清,通利六阳之会首,祛除诸热之风邪,同川芎达巅顶,以导壅滞之热。取其气香而利窍,善走肌表,用消浮肿,散肌热;珍珠粉外用于伤口能填充组织间隙,粘连血管组织,发挥其消炎、促进胶原细胞生长的功效,促使机体细胞再生;黄芪用于疮疡久不溃破而内陷,有促进溃破及局限作用;红花可活血行气,祛瘀通络,通痹止痛;白毛藤有祛风湿,通经络和止痛的功能,治疗胃痛、筋骨痛等功效;何首乌内调气血,外散疮痈、 能养血益肝,固精益肾,健筋骨;紫草性寒,有清热凉血、解毒、透疹之功,还具有杀菌消毒的功效;三七散瘀止血,消肿定痛;透骨草舒筋活络、祛风除湿、解毒化疹;狗脊祛风湿,补肝肾,强腰膝;蝎尾入肝祛风;黄柏有清热燥湿,泻火除蒸,解毒疗疮的功效;鱼腥草能清热解毒、消肿疗疮、利尿除湿、清热止痢;煅牡蛎收敛固涩,制酸止痛,重镇安神,软坚散结;血竭活血定痛,化瘀止血,敛疮生肌;水蛭破血通经,逐瘀消症;鹿角胶温补肝肾,益精养血。
本发明提供的治疗褥疮的中药,具有活血化於,生肌、祛风止痛的效果,还具有止血、化脓、消炎、去腐生肌的效果,治疗患处时能及时清除坏死组织,创面清洁有利于肉芽及上皮的再生,和现有技术相比,具有药效显著、治疗周期短、用药安全、可靠,方法简便、易行的特点。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷25份、珍珠粉15份、黄芪30份、红花25份、川芎15份、白毛藤10份、何首乌15份、紫草10份、三七10份、透骨草5份、狗脊12份、蝎尾10份、黄柏5份、鱼腥草10份、煅牡蛎5份、血竭8份、水蛭3份、鹿角胶5份。
所述临床护理上用于治疗褥疮的中药组合物的制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入海藻酸钠、没食子酸烷酯和丁子香酚复配制成中药软膏。
陈XX,女,56岁,双下肢瘫痪,骶尾部可见一处坏死溃疡期的褥疮,可见尾骨,皮肤缺损,周围形成窦道,有少量脓性分泌物。将本发明中药均匀涂抹在凹陷处及创面,然后用无菌纱布包扎,包扎部位应避免受压,连续用药2周后疗程后,创面疮口明显缩小,且有较多的肉芽生长,使用1个月后创面完全愈合,随访至今未复发。
实施例2:
一种临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷30份、珍珠粉20份、黄芪28份、红花18份、川芎15份、白毛藤20份、何首乌20份、紫草18份、三七18份、透骨草15份、狗脊6份、蝎尾10份、黄柏10份、鱼腥草8份、煅牡蛎3份、血竭5份、水蛭3份、鹿角胶5份。
所述临床护理上用于治疗褥疮的中药组合物的制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却 至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入卡波姆、果胶、酒石酸、茴香醚复配制成中药软膏。
李XX,男,80岁,患者偏瘫卧床并发褥疮。检查右背部有黑痣褥疮,周围红肿明显,黑痣按之有波动感,可挤压出少许脓性分泌物,坏死组织深及肌层,将本发明药物均匀涂敷在疮面上,两周后疮面新生肉芽组织形成,1月后疮口愈合,无疤痕,随访至今未复发。
实施例3:
一种临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷20份、珍珠粉20份、黄芪35份、红花10份、川芎5份、白毛藤15份、何首乌8份、紫草15份、三七3份、透骨草5份、狗脊15份、蝎尾6份、黄柏3份、鱼腥草5份、煅牡蛎3份、血竭3份、水蛭份、鹿角胶3份。
所述临床护理上用于治疗褥疮的中药组合物的制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加 入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入PEG、凡士林、异抗坏血酸复配制成中药软膏。
张XX,男,71岁,长期卧床,大腿部褥疮两处2×1.5、3×2.5,左手肘部,左肋骨、有小红斑,血水疱,呈暗紫色,且已溃疡,四周皮肤红肿胀,左髋部局部皮肤破损,左髋部有腐肉脱落,溃疡,不长口,有少量脓液流出,临床诊断为褥疮,住院后采用常规方法综合治疗,无显著效果,后使用本发明中药后,两个月后血水疱已好,左髋部已无脓液,皮肤鲜嫩,继续使用1个月后,皮肤已长好,无其它任何症状,随访至今未复发。。
实施例4:
一种临床护理上用于治疗褥疮的中药组合物,由以下重量份的中药制成:薄荷35份、珍珠粉15份、黄芪5份、红花20份、川芎20份、白毛藤5份、何首乌15份、紫草18份、三七15份、透骨草10份、狗脊10份、蝎尾12份、黄柏10份、鱼腥草3份、煅牡蛎8份、血竭8份、水蛭5份、鹿角胶5份。
所述临床护理上用于治疗褥疮的中药组合物的制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入硬脂酸、麝香草酚、巯基二丙酸复配制成中药软膏。
吴XX,男,59岁,因脑溢血,自已不能自理长期卧床不起脊椎体隆突处、骶尾部皮肤已破损溃疡,有腐肉脱落,有少量脓液流,使用本发明药物,两周后脊椎体隆突处、骶尾部皮肤已无脓液流出,且有红色肉芽长出,其它诸症均已改善,继续使用2月后,脊椎体隆突处溃疡面基本长好,骶尾部有口没有好,其它症状完全消失,使用半年后一切症状完全消失,皮肤已长好,无其它任何症状,随访至今未复发。
诊断标准:创面周围伴有红、肿、热、痛局部炎症,如果还有化脓、恶臭症状者即可认定为局部感染征兆,伴发热则说明具有全身反应。多见于截瘫、慢性消耗性疾患、大面积烧伤及深度昏迷等长期卧床患者。多发于骶骨、坐骨结节等骨隆突处。在持续受压部位出现红斑、水疱、溃疡三步曲病理改变。
疗效观察:痊愈:经治疗创面完全愈合;显效:经治疗后创面缩小明显有较多的肉芽生长;好转:经治疗创面腐烂组织已清除,分泌物减少;无效:治疗前后创面无变化。
结果:总病例数60例,痊愈27例,显效10例,好转19例,无效4例,总有效率93.3%,且无毒副作用。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的 情况下,由语句“包括一个......”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。
以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (8)
1.一种临床护理上用于治疗褥疮的中药组合物,其特征在于,由以下重量份的中药制成:薄荷20~35份、珍珠粉15~20份、黄芪5~35份、红花10~25份、川芎5~20份、白毛藤5~20份、何首乌8~20份、紫草10~18份、三七3~18份、透骨草5~15份、狗脊6~15份、蝎尾6~12份、黄柏3~10份、鱼腥草3~10份、煅牡蛎3~8份、血竭3~8份、水蛭3~5份、鹿角胶3~5份。
2.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,由以下重量份的中药制成:薄荷25份、珍珠粉15份、黄芪30份、红花25份、川芎15份、白毛藤10份、何首乌15份、紫草10份、三七10份、透骨草5份、狗脊12份、蝎尾10份、黄柏5份、鱼腥草10份、煅牡蛎5份、血竭8份、水蛭3份、鹿角胶5份。
3.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,由以下重量份的中药制成:薄荷30份、珍珠粉20份、黄芪28份、红花18份、川芎15份、白毛藤20份、何首乌20份、紫草18份、三七18份、透骨草15份、狗脊6份、蝎尾10份、黄柏10份、鱼腥草8份、煅牡蛎3份、血竭5份、水蛭3份、鹿角胶5份。
4.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,所述临床护理上用于治疗褥疮的中药组合物与软膏基质、抗氧剂或防腐剂复配可制成中药软膏。
5.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,所述软膏基质为凡士林、石蜡、羊毛脂、蜂蜡、鲸蜡、二甲基硅油、硬脂酸、十八醇、植物油、PEG、FAPG、海藻酸钠、皂土、卡波姆、果胶中的一种或多种组合物。
6.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,所述抗氧剂为VE、没食子酸烷酯、丁羟基茴香醚、丁羟基甲苯、抗坏血酸、异抗坏血酸、亚硫酸盐、枸橼酸、酒石酸、巯基二丙酸中的一种或多种组合物。
7.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,所述防腐剂为异丙醇、氯丁醇、三氯叔丁醇、苯基-对-氯苯丙二醇、苯氧乙醇、溴硝基丙二醇、苯甲酸、丙酸、山梨酸、肉桂酸、茴香醚、香茅醛、丁子香酚、香兰酸酯、苯酚、苯甲酚、麝香草酚、对氯邻甲苯酚、对氯间二甲苯酚、煤酚、氯代百里酚、水杨酸、对羟基苯甲酸酯、苯扎氯铵、溴化烷基三甲基铵、葡萄糖酸洗必泰中的一种或多种。
8.如权利要求1所述的临床护理上用于治疗褥疮的中药组合物,其特征在于,其制备方法,包括以下步骤:
(1)将薄荷、黄芪、红花、川芎、白毛藤、何首乌、紫草、三七、透骨草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭研磨成分,备用,再将珍珠放入豆浆中,升温至80~100℃,保温2~3h,然后冷却至室温,研磨成细粉;
(2)将黄芪、川芎、白毛藤、何首乌、紫草、狗脊、蝎尾、黄柏、鱼腥草、煅牡蛎、血竭、水蛭加入1~2倍的水中,大火蒸煮15~20min,然后加入鹿角胶转小火继续蒸煮30~90min,自然冷却至室温后,再加入薄荷、红花、三七、透骨草和珍珠粉,得到糊状中药混合物;
(3)在糊状中药混合物中加入软膏基质、抗氧剂或防腐剂复配制成中药软膏。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611002705.2A CN106511676A (zh) | 2016-11-15 | 2016-11-15 | 一种临床护理上用于治疗褥疮的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611002705.2A CN106511676A (zh) | 2016-11-15 | 2016-11-15 | 一种临床护理上用于治疗褥疮的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106511676A true CN106511676A (zh) | 2017-03-22 |
Family
ID=58353245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611002705.2A Pending CN106511676A (zh) | 2016-11-15 | 2016-11-15 | 一种临床护理上用于治疗褥疮的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106511676A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101249A (zh) * | 2019-05-15 | 2019-08-09 | 黄冬生 | 一种马尾毛填充体及其制作方式 |
| CN110755265A (zh) * | 2019-11-13 | 2020-02-07 | 辽宁中医药大学附属医院 | 一种无痛微针及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893557A (zh) * | 2014-03-10 | 2014-07-02 | 许建成 | 一种治疗褥疮的中药制剂 |
| CN105250712A (zh) * | 2015-11-16 | 2016-01-20 | 赵小茜 | 一种治疗褥疮的中药组合物 |
| CN105726789A (zh) * | 2016-03-17 | 2016-07-06 | 张金爱 | 一种用于治疗褥疮的护理药物制剂及其用途 |
-
2016
- 2016-11-15 CN CN201611002705.2A patent/CN106511676A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893557A (zh) * | 2014-03-10 | 2014-07-02 | 许建成 | 一种治疗褥疮的中药制剂 |
| CN105250712A (zh) * | 2015-11-16 | 2016-01-20 | 赵小茜 | 一种治疗褥疮的中药组合物 |
| CN105726789A (zh) * | 2016-03-17 | 2016-07-06 | 张金爱 | 一种用于治疗褥疮的护理药物制剂及其用途 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101249A (zh) * | 2019-05-15 | 2019-08-09 | 黄冬生 | 一种马尾毛填充体及其制作方式 |
| CN110755265A (zh) * | 2019-11-13 | 2020-02-07 | 辽宁中医药大学附属医院 | 一种无痛微针及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
| CN108186711A (zh) | 促进伤口愈合的药物组合物 | |
| CN110292602A (zh) | 一种复方五黄烧伤油配方及其制备方法 | |
| CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
| CN102698086B (zh) | 一种治疗褥疮蕴毒腐溃证的中药乳剂 | |
| CN106728615A (zh) | 用于接骨生骨的中药组合物及其制备方法 | |
| CN105535508A (zh) | 一种芪竭愈创膏及制备方法 | |
| CN114886967B (zh) | 一种生肌外用中药组合物及制备方法 | |
| CN101869636A (zh) | 紫油生肌膏 | |
| CN101028365B (zh) | 一种治疗烧、烫伤的药物及其制备方法 | |
| CN105250712B (zh) | 一种治疗褥疮的中药组合物 | |
| CN101347535B (zh) | 一种烧、烫、灼伤再生膏 | |
| CN103830437B (zh) | 一种用于加快骨折消肿的熏洗护理液 | |
| CN106806545A (zh) | 一种化腐生肌中草药组合物及其制备方法 | |
| CN104083421A (zh) | 治疗褥疮的中药药膏及其制备方法 | |
| CN104306707A (zh) | 一种治疗褥疮的药物组合物 | |
| CN102284006A (zh) | 一种治疗褥疮及烧烫创伤的外用膏剂 | |
| CN116531460B (zh) | 一种治疗巨大褥疮的中药散剂及其制备方法 | |
| CN118286339B (zh) | 一种中药油及其制备方法和应用 | |
| CN102824599B (zh) | 一种治疗糖尿病引起的各种皮肤溃烂的中药酊剂 | |
| CN111939203B (zh) | 一种治疗糖尿病足中药软膏制剂及其制备方法 | |
| CN105596766A (zh) | 一种褥疮护理中药药膏及其制备方法 | |
| CN116870072A (zh) | 中药组合物、应用、凝胶剂和凝胶剂的制备方法 | |
| CN106511825A (zh) | 一种用于褥疮护理的中药 | |
| CN118121668A (zh) | 一种烧烫伤中药及其配制方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |
|
| RJ01 | Rejection of invention patent application after publication |